Talin Tallar

MDHow is an online platform that leverages AI to provide personalized medical advice to patients while connecting them with the right healthcare professionals.

Stealth Company.

Kalderos delivers technology that solves the challenges facing the US healthcare system. We work with healthcare providers, drug manufacturers, payers, and government agencies alike to increase transparency and restore trust — lowering the cost of healthcare and enabling everyone to focus on improving the health of people.

Cerevel Therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (CNS). The company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of CNS disorders, including Parkinson’s, Alzheimer’s, epilepsy, schizophrenia and addiction. Headquartered in the Greater Boston area, Cerevel was formed in 2018 through a partnership between Bain Capital and Pfizer.

Launched in the US in 2023, NuvoAir is a purpose-built, integrated specialty care platform that is reinventing the operating model through which care to complex cardiopulmonary patients is delivered. We emphasize the management of exacerbations, the key contributors to high healthcare costs and longitudinal care. Our platform empowers physicians, helping them maintain autonomy, deliver outstanding care and enhance their revenue in ways previously unattainable. By collaborating with health plans, risk-bearing entities, and innovative cardiologists and pulmonologists, we have redefined how patients with complex heart and lung issues, receive high quality care. To discover more about how NuvoAir is advancing high-value care in the cardiopulmonary space and to explore NuvoAirs extensive body of clinical evidence, visit nuvoair.com. Our recruiting email is talent@nuvoair.com, do not hesitate to reach out for any open position. Erin Murphree will be reaching out to you within short notice!

Artera, a SaaS leader in digital health, transforms patient experience with AI-powered virtual agents (voice and text) for every step of the patient journey. Trusted by 900+ provider organizations — including specialty groups, FQHCs, large IDNs and federal agencies — engaging 100 million patients annually. Artera’s virtual agents support front desk staff to improve patient access including self-scheduling, intake, forms, billing and more. Whether augmenting a team or unleashing a fully autonomous digital workforce, Artera offers multiple virtual agent options to meet healthcare organizations where they are in their AI journey. Artera helps support 2B communications in 109 languages across voice, text and web. A decade of healthcare expertise, powered by AI.

Our mission is to grow the small business economy 🤝 Trusted by 400K+ businesses with HR, payroll, benefits, 401(k)s, and more. Licensing details: https://gusto.com/about/licenses

MDHow is an online platform that leverages AI to provide personalized medical advice to patients while connecting them with the right healthcare professionals.

J&J Innovation Asia Pacific will partner with the Janssen R&D Immunology TA to host a hybrid onsite and online Science and Partnering forum convening global and regional leaders to engage in a dialogue on opportunities for accelerating solutions for patients with immune-mediated diseases through deals and incubation. The event will focus on engaging audiences of early-stage innovators in China, Japan and South Korea. The event will bring together internal and external experts to present and engage in panel discussions on current and future trends in immunology R&D and commercialization, as well as Janssen and Johnson & Johnson’s innovations approach to partnership with early-stage innovators in this therapeutic area, with a particular focus on the topics related to small molecule and platform solutions that address immune-mediated diseases impacting patients everywhere.

Stealth Company.

Kalderos delivers technology that solves the challenges facing the US healthcare system. We work with healthcare providers, drug manufacturers, payers, and government agencies alike to increase transparency and restore trust — lowering the cost of healthcare and enabling everyone to focus on improving the health of people.